Tasly Pharmaceutical Group Co., Ltd Reveals Rise In Nine Months Bottom Line

India, Oct. 24 -- Tasly Pharmaceutical Group Co., Ltd (600535.SS) released earnings for its nine months that Increased, from last year

The company's bottom line came in at RMB1.102 billion, or RMB0.74 per share. This compares with RMB984.373 million, or RMB0.66 per share, last year.

The company's revenue for the period fell 3.8% to RMB6.073 billion from RMB6.310 billion last year.

Tasly Pharmaceutical Group Co., Ltd earnings at a glance (GAAP) :

-Earnings: RMB1.102 Bln. vs. RMB984.373 Mln. last year.-EPS: RMB0.74 vs. RMB0.66 last year.-Revenue: RMB6.073 Bln vs. RMB6.310 Bln last year.

For comments and feedback contact: [e-mail]

Published by HT Digital Content Services with permission from RTT News....